Quantamental Technologies LLC Cytom X Therapeutics, Inc. Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$7.38 - $12.25 $5,261 - $8,734	-713 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$9.35 - $11.41 $6,666 - $8,135	713 New	713 $8,000
Q1 2019 Apr 29, 2019	SELL	$9.5 - $19.16 $8,341 - $16,822	-878 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$12.69 - $18.61 $11,141 - $16,339	878 New	878 $13,000

50.2M

22.3K

22.9K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $79.8M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.